Physician profile
Corey Waldman
NPI 1871851832
$935.27
in general payments reported to CMS, 2019-2025
11 companies · $450 in 2025
The $450 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79.53 · 2020: $129 · 2021: $26.72 · 2022: $56.52 · 2023: $159 · 2024: $34.35 · 2025: $450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $643.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $284.26 | 2025 | |
| Allergan, INC. | $197.09 | 2019-2020 | |
| Rxsight INC | $128.04 | 2021-2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Alcon Vision LLC | $120.46 | 2022-2025 | Clareon, Clareon Panoptix Pro, Hydrus Microstent |
| Sight Sciences, INC. | $44.86 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Ocular Therapeutix, INC. | $37.49 | 2022 | |
| Edwards Lifesciences Corporation | $37.23 | 2023 | Sapien 3 Ultra Resilia |
| Johnson & Johnson Surgical Vision, INC. | $26.62 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $25.49 | 2025 | Envista Envy Iol |
| Apellis Pharmaceuticals, INC. | $21.06 | 2025 | Syfovre |
| New World Medical,INC. | $12.67 | 2024 | Clearpath, Streamline, Kahook Dual Blade |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corey Waldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.